Clinical Trials in Bassano del Grappa, Italy
5 recruiting
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Primary Immune Thrombocytopenia (ITP)
argenx69 enrolled94 locationsNCT06544499
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled759 locationsNCT06742723
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Fabry Disease
Genzyme, a Sanofi Company9,000 enrolled283 locationsNCT00196742
Recruiting
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, PNH
Novartis Pharmaceuticals50 enrolled7 locationsNCT07229235
Recruiting
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
Low Grade Non-Hodgkin's Lymphoma, Adult
Fondazione Italiana Linfomi - ETS150 enrolled20 locationsNCT05524298
Recruiting
Not Applicable
Effects of a Dietary Supplement Composed of Diosmin, Hesperidin, Bromelain, and Ruscus Aculeatus on the Quality of Life in Subjects With Lower Limb Disorders Possibly Prodromal to Chronic Venous Disease
Prodromal to Chronic Venous Disease
Ekalab S.r.l.84 enrolled6 locationsNCT07185386
Recruiting
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria
Swedish Orphan Biovitrum200 enrolled75 locationsNCT05776472
Recruiting
OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
Oligometastatic Prostate Carcinoma
Istituto Oncologico Veneto IRCCS150 enrolled12 locationsNCT06273345
Recruiting
Health-care Quality in Semi-intensive Care Units
EvaluationSemi-intensive Care UnitQuality
Mario Negri Institute for Pharmacological Research39,000 enrolled25 locationsNCT04676347